These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29140522)

  • 1. ECOdrug: a database connecting drugs and conservation of their targets across species.
    Verbruggen B; Gunnarsson L; Kristiansson E; Österlund T; Owen SF; Snape JR; Tyler CR
    Nucleic Acids Res; 2018 Jan; 46(D1):D930-D936. PubMed ID: 29140522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments.
    Gunnarsson L; Jauhiainen A; Kristiansson E; Nerman O; Larsson DG
    Environ Sci Technol; 2008 Aug; 42(15):5807-13. PubMed ID: 18754513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended Multitarget Pharmacology of Anticancer Drugs.
    Shi D; Khan F; Abagyan R
    J Chem Inf Model; 2019 Jun; 59(6):3006-3017. PubMed ID: 31025863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open Targets Platform: supporting systematic drug-target identification and prioritisation.
    Ochoa D; Hercules A; Carmona M; Suveges D; Gonzalez-Uriarte A; Malangone C; Miranda A; Fumis L; Carvalho-Silva D; Spitzer M; Baker J; Ferrer J; Raies A; Razuvayevskaya O; Faulconbridge A; Petsalaki E; Mutowo P; Machlitt-Northen S; Peat G; McAuley E; Ong CK; Mountjoy E; Ghoussaini M; Pierleoni A; Papa E; Pignatelli M; Koscielny G; Karim M; Schwartzentruber J; Hulcoop DG; Dunham I; McDonagh EM
    Nucleic Acids Res; 2021 Jan; 49(D1):D1302-D1310. PubMed ID: 33196847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
    Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CancerDR: cancer drug resistance database.
    Kumar R; Chaudhary K; Gupta S; Singh H; Kumar S; Gautam A; Kapoor P; Raghava GP
    Sci Rep; 2013; 3():1445. PubMed ID: 23486013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of emerging genomics and proteomics technologies in cancer drug target discovery.
    Onyango P
    Curr Cancer Drug Targets; 2004 Mar; 4(2):111-24. PubMed ID: 15032664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems pharmacology strategies for anticancer drug discovery based on natural products.
    Luo F; Gu J; Chen L; Xu X
    Mol Biosyst; 2014 Jul; 10(7):1912-7. PubMed ID: 24802653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCMDB: the human cancer metastasis database.
    Zheng G; Ma Y; Zou Y; Yin A; Li W; Dong D
    Nucleic Acids Res; 2018 Jan; 46(D1):D950-D955. PubMed ID: 29088455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying putative drug targets and potential drug leads: starting points for virtual screening and docking.
    Wishart DS
    Methods Mol Biol; 2015; 1215():425-44. PubMed ID: 25330974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. canSAR: update to the cancer translational research and drug discovery knowledgebase.
    Coker EA; Mitsopoulos C; Tym JE; Komianou A; Kannas C; Di Micco P; Villasclaras Fernandez E; Ozer B; Antolin AA; Workman P; Al-Lazikani B
    Nucleic Acids Res; 2019 Jan; 47(D1):D917-D922. PubMed ID: 30496479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel drugs for promising targets.
    Martell RE; Brooks DG; Wang Y; Wilcoxen K
    Clin Ther; 2013 Sep; 35(9):1271-81. PubMed ID: 24054704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of mechanism of action biology-driven early drug development for children with cancer.
    Pearson AD; Herold R; Rousseau R; Copland C; Bradley-Garelik B; Binner D; Capdeville R; Caron H; Carleer J; Chesler L; Geoerger B; Kearns P; Marshall LV; Pfister SM; Schleiermacher G; Skolnik J; Spadoni C; Sterba J; van den Berg H; Uttenreuther-Fischer M; Witt O; Norga K; Vassal G;
    Eur J Cancer; 2016 Jul; 62():124-31. PubMed ID: 27258969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CR2Cancer: a database for chromatin regulators in human cancer.
    Ru B; Sun J; Tong Y; Wong CN; Chandra A; Tang ATS; Chow LKY; Wun WL; Levitskaya Z; Zhang J
    Nucleic Acids Res; 2018 Jan; 46(D1):D918-D924. PubMed ID: 29036683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural diversity of the epigenetics pocketome.
    Cabaye A; Nguyen KT; Liu L; Pande V; Schapira M
    Proteins; 2015 Jul; 83(7):1316-26. PubMed ID: 25974248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current situation and future usage of anticancer drug databases.
    Wang H; Yin Y; Wang P; Xiong C; Huang L; Li S; Li X; Fu L
    Apoptosis; 2016 Jul; 21(7):778-94. PubMed ID: 27193464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic lethality as an engine for cancer drug target discovery.
    Huang A; Garraway LA; Ashworth A; Weber B
    Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
    Perry WL; Weitzman A
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):199-202, 237-8. PubMed ID: 16166991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells.
    Hu X; Cong Y; Luo HH; Wu S; Zhao LE; Liu Q; Yang Y
    Stem Cells Transl Med; 2017 Feb; 6(2):331-334. PubMed ID: 28191780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TarNet: An Evidence-Based Database for Natural Medicine Research.
    Hu R; Ren G; Sun G; Sun X
    PLoS One; 2016; 11(6):e0157222. PubMed ID: 27337171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.